Drexel, H, Lewis, B S, Rosano, G M C, Saely, C H, Tautermann, G, Huber, K, Dopheide, J F, Kaski, J C, Mader, A, Niessner, A, Savarese, G, Schmidt, T A, Semb, A, Tamargo, J, Wassmann, S, Kjeldsen, K P, Agewall, S & Pocock, S J 2021, ' The age of randomized clinical trials : three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 7, no. 5, pp. 453–459 . https://doi.org/10.1093/ehjcvp/pvaa126
Magavern, E F, Kaski, J C, Turner, R M, Drexel, H, Janmohamed, A, Scourfield, A, Burrage, D, Floyd, C N, Adeyeye, E, Tamargo, J, Lewis, B S, Kjeldsen, K P, Niessner, A, Wassmann, S, Sulzgruber, P, Borry, P, Agewall, S, Semb, A G, Savarese, G, Pirmohamed, M & Caulfield, M J 2022, ' Challenges in Cardiovascular Pharmacogenomics Implementation : A viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 1, pp. 100-103 . https://doi.org/10.1093/ehjcvp/pvab063 EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY
Drexel, H, Pocock, S J, Lewis, B S, Saely, C H, Kaski, J C, Rosano, G M C, Tautermann, G, Huber, K, Dopheide, J F, Mader, A, Niessner, A, Savarese, G, Schmidt, T A, Semb, A G, Tamargo, J, Wassmann, S, Clodi, M, Kjeldsen, K P & Agewall, S 2022, ' Subgroup analyses in randomized clinical trials : value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 3, pp. 302-310 . https://doi.org/10.1093/ehjcvp/pvab048 Drexel, H, Pocock, S J, Lewis, B S, Saely, C H, Kaski, J C, Rosano, G M C, Tautermann, G, Huber, K, Dopheide, J F, Mader, A, Niessner, A, Savarese, G, Schmidt, T A, Semb, A G, Tamargo, J, Wassmann, S, Clodi, M, Kjeldsen, K P & Agewall, S 2022, ' Subgroup analyses in randomized clinical trials : Value and limitations Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 3, pp. 302-310 . https://doi.org/10.1093/ehjcvp/pvab048
Krogager, M L, Kragholm, K, Thomassen, J Q, Søgaard, P, Lewis, B S, Wassmann, S, Baumgartner, I, Ceconi, C, Schmidt, T A, Kaski, J C, Drexel, H, Semb, A G, Agewall, S, Niessner, A, Savarese, G, Kjeldsen, K P, Borghi, C, Tamargo, J & Torp-Pedersen, C 2021, ' Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease : A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 7, no. 6, pp. 557-567 . https://doi.org/10.1093/ehjcvp/pvab038
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY Magavern, E F, Kaski, J C, Turner, R M, Drexel, H, Janmohamed, A, Scourfield, A, Burrage, D, Floyd, C N, Adeyeye, E, Tamargo, J, Lewis, B S, Kjeldsen, K P, Niessner, A, Wassmann, S, Sulzgruber, P, Borry, P, Agewall, S, Semb, A G, Savarese, G, Pirmohamed, M & Caulfield, M J 2022, ' The Role of Pharmacogenomics in Contemporary Cardiovascular Therapy : A position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 8, no. 1, pp. 85-99 . https://doi.org/10.1093/ehjcvp/pvab018
Savarese, G, Reiner, M F, Uijl, A, D'Amario, D, Agewall, S, Atar, D, Baumgartner, I, Borghi, C, De Carlo, M, Drexel, H, Kaski, J C, Kjeldsen, K P, Kucher, N, Lund, L H, Niessner, A, Semb, A G, Schmidt, T A, Sulzgruber, P, Tamargo, J, Vitale, C, Wassmann, S, Aboyans, V & Lewis, B S 2020, ' Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease : systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 2, pp. 86-93 . https://doi.org/10.1093/ehjcvp/pvz036 Savarese, Gianluigi; Reiner, Martin F; Uijl, Alicia; D Amario, Domenico; Agewall, Stefan; Atar, Dan; Baumgartner, Iris; Borghi, Claudio; De Carlo, Marco; Drexel, Heinz; Kaski, Juan Carlos; Kjeldsen, Keld P; Kucher, Nils; Lund, Lars H; Niessner, Alexander; Semb, Anne Grete; Schmidt, Thomas A; Sulzgruber, Patrick; Tamargo, Juan; Vitale, Cristiana; ... (2020). Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases. European heart journal-cardiovascular pharmacotherapy, 6(2), pp. 86-93. Oxford University Press 10.1093/ehjcvp/pvz036 Savarese, G, Reiner, M F, Uijl, A, D´Amario, D, Agewall, S, Atar, D, Baumgartner, I, Borghi, C, De Carlo, M, Drexel, H, Kaski, J C, Kjeldsen, K P, Kucher, N, Lund, L H, Niessner, A, Semb, A G, Schmidt, T A, Sulzgruber, P, Tamargo, J, Vitale, C, Wassmann, S, Aboyans, V & Lewis, B S 2020, ' Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease : Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases ', European Heart Journal-Cardiovascular Pharmacotherapy, vol. 6, no. 2, pp. 86-93 . https://doi.org/10.1093/ehjcvp/pvz036 European heart journal-Cardiovascular pharmacotherapy, 6(2), 86